Outlook Therapeutics Files 8-K
Ticker: OTLK · Form: 8-K · Filed: May 23, 2025 · CIK: 1649989
| Field | Detail |
|---|---|
| Company | Outlook Therapeutics, Inc. (OTLK) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-event, filing
Related Tickers: OTLK
TL;DR
OTLK filed an 8-K on 5/23 for an event on 5/22 - check it out.
AI Summary
Outlook Therapeutics, Inc. filed an 8-K on May 23, 2025, reporting an event on May 22, 2025. The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits'. The company, formerly known as Oncobiologics, Inc., is incorporated in Delaware and has its principal executive offices in Iselin, New Jersey.
Why It Matters
This 8-K filing indicates a significant event or update from Outlook Therapeutics, Inc., requiring immediate disclosure to investors.
Risk Assessment
Risk Level: medium — 8-K filings can signal significant corporate events, requiring investors to assess the impact on the company's future performance.
Key Players & Entities
- Outlook Therapeutics, Inc. (company) — Registrant
- Oncobiologics, Inc. (company) — Former company name
- May 22, 2025 (date) — Earliest event reported
- May 23, 2025 (date) — Filing date
- 001-37759 (other) — SEC File Number
FAQ
What specific event triggered this 8-K filing?
The filing does not specify the exact event, only that it occurred on May 22, 2025, and falls under 'Other Events' and 'Financial Statements and Exhibits'.
When was Outlook Therapeutics, Inc. previously known by another name?
The company was formerly known as Oncobiologics, Inc., with a date of name change on August 4, 2015.
What is the principal executive office address for Outlook Therapeutics, Inc.?
The principal executive offices are located at 111 S. Wood Avenue, Unit #100, Iselin, New Jersey 08830.
What is the fiscal year end for Outlook Therapeutics, Inc.?
The fiscal year end for Outlook Therapeutics, Inc. is September 30.
What is the SIC code for Outlook Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Outlook Therapeutics, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding Outlook Therapeutics, Inc. (OTLK).